Drawing for IPS STOCK

USPTO serial 79296113

IPS STOCK

Reviewed by CopyMark Law Group

Reg. 6481108Status 700Renewal
Filing date
Status date
Registration date
Sep 14, 2021
Examiner
SAUNDERS, ANDREA DAWN
Law office
TMO LAW OFFICE 137

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IPS STOCK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dawn Rudenko

Dawn Rudenko Holland & Knight LLP263 Tresser BlvdOne Stamford Plaza, Ste1400Stamford, CT 06901

Goods and services

ClassDescriptionStatusFirst use
001Stem cells for research and scientific purposes; stem cells, other than for medical or veterinary purposes; industrial chemicals; chemical test paper, other than for medical purposes; cell culture reagents for laboratory use; cell culture media for scientific or research purposes; biological preparation for use in cell cultures other than for medical or veterinary useACTIVE—
005Stem cells for medical and clinical purposes; pharmaceutical preparations for use in regenerative therapy; test paper being reagent paper for medical purposes; living cells for medical use; cells for medical use; tissues for medical use, namely, biological tissue cultures for medical purposesACTIVE—
039Storage of frozen living cells; storage of biological tissues, cells and stem cells; warehousing services for deposited articlesACTIVE—
042Scientific research on stem cells; cell culture services for scientific and research purposes, for others; cytogenetic examination for research purposes; testing, examination, research and development in the field of cytology; testing, examination, research and development in the field of regenerative medicine; testing, examination, research and development of pharmaceuticals; clinical studies; medical laboratory services; providing quality assurance in the field of cells; quality control for others; providing information on medical research in the field of medical therapy; providing information on medical research and testing related to stem cells; providing information related to research and development of pharmaceutical preparations; testing, examination and research of medical therapy methods and technologies; testing, examination and research of cosmetics and foods; design and development of computer hardware and computer software for use in the field of medical science; design and development of machines, apparatus, instruments and systems in the field of medical science; design, development and maintenance of computer programs; testing and research on machines, apparatus, and instruments in the field of medical science ; rental of laboratory apparatus and instrumentsACTIVE—
044Stem cell therapy services; providing medical information in the field of cells; providing medical information on regenerative medicine; providing medical information; collection and preservation of biological tissues, blood and cells; medical treatment and diagnosis services in the nature of regenerative therapy by using a cell culture; cell culture bank services for medical transplantation; medical care; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis in the nature of regenerative therapy by regenerative medicine; medical cell therapy and diagnosis services in the nature of regenerative cell therapy; medical treatment and consulting services in the nature of regenerative cell therapy by cell preparations; preservation of human blood for stem cells; providing medical information and medical record analysis for use in medical treatment; clinical medical examination services; providing health care services; preparation and dispensing of medications; physical examination services; dentistry services; providing health information; dietary and nutritional guidance; rental of medical apparatus and instrumentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 14, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 19, 2023LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 5, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Mar 21, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 1, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 28, 2022FIMPFINAL DISPOSITION PROCESSED—
Dec 14, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 26, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 14, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 29, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 29, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 9, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 21, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 21, 2021XAECEXAMINER'S AMENDMENT ENTERED—
May 21, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 21, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
May 21, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
May 14, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 14, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 14, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2020RFNTREFUSAL PROCESSED BY IB—
Nov 16, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 16, 2020RFRRREFUSAL PROCESSED BY MPU—
Oct 27, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 26, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 19, 2020DOCKASSIGNED TO EXAMINER—
Oct 19, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 15, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance